Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Boehringer Ingelheim
Boehringer Ingelheim
BeOne Medicines
QuantumLeap Healthcare Collaborative
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Emory University
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
M.D. Anderson Cancer Center
Fujian Medical University Union Hospital
UNICANCER